Biofrontera Ag (BFRA) Return on Investment ROI from the fourth quarter of 2018 to fourth quarter of 2017 and for the year 2018, average high and low, overall ranking from Dec 31 2018 to Dec 31 2017 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biofrontera Ag  (BFRA)


Biofrontera Ag's ROI from its fourth quarter of 2018 to the fourth quarter of 2017 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biofrontera Ag's ROI in the fourth quarter of 2018?
Biofrontera Ag recorded a cumulative net loss of $-10 million during 12 months ending in the fourth quarter of 2018, resulting in a negative return on investment (ROI) of -16.85%.

Within the Healthcare sector 353 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2018 from 0 to 4306.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2018)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2017)
IV. Quarter
Y / Y Investment Change TTM 67.52 % 87.39 % 134.55 % 225.19 % 426.9 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 59 49 53 75 36
Return On Investment (TTM) -16.85 % -30.27 % -32.45 % -35.57 % -45.7 %
BFRA's Overall Ranking # 4306 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 10.94 % 7.21 % 9.61 % 28.49 % 24.1 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -10 -16 -16 -16 -16

BFRA Company Profile >> Back to BFRA Roi Comparisons >> See Annual BFRA Return On Investment



Return On Investment BFRA's Ranking
Within: No.
Industry # 144
Sector # 354
Overall # 4306

Return On Investment Statistics
High Average Low
-15.68 %
-23.08 %
-28.31 %
(Dec 31 2019)   (Dec 31 2018)







Financial Statements
Biofrontera Ag's IV. Quarter Investments $ 59 Millions BFRA's Balance sheet
Biofrontera Ag's IV. Quarter Income $ -10 Millions Quarterly BFRA's Income Statement
BFRA's Income by Division See BFRA's Income by Division


BFRA Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 59 53 36 6 0
Y / Y Investment Growth 12.01 % 47.77 % 474.25 % - -
Net Income in Millions -15 -8 -10 -18 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -25.26 % -15.68 % -29.51 % -293.97 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BFRA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BFRA's Competitors
Subscribers only: Roi for Biofrontera Ag's Suppliers
Subscribers only: Return On Investment for BFRA's Customers

Other Ratios
BFRA's Roa BFRA's Inventory Turnover Ratio BFRA's Growth Rates BFRA's Dividend Statistics
BFRA's Profitability Ratios BFRA's Asset Turnover Ratio BFRA's Dividend Growth
BFRA's Roe BFRA's Valuation Ratios BFRA's Financial Strength Ratios BFRA's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2018, within Healthcare Sector ROI

Date modified: 2026-09-08T15:09:32+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.